Neurology and Neurosurgery

Episodes 76-90 of 94

• 

  RestartResume

  An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs

  CME/CE

  An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs

  • 

    

    James R. Bateman, MD, MPH

    Peer

  • 

    

    Jerome A. Barakos, MD

    Peer

  • 

    

    Danya Khoujah, MBBS, MEHP, FACEP, FAAEM

    Peer

  • 

    

    B. Joy Snider, MD, PhD

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  0.50 credits

• 

  MinuteCE®

  Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 credits 10 episodes

• 

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  MinuteCE®

  Decoding CIDP: Exploring Common and Atypical Variants

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  MinuteCE®

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  MinuteCE®

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits
• advertisement

• 

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  MinuteCE®

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  MinuteCE®

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  MinuteCE®

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  • 

    

    Jeffrey Allen, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  MinuteCE®

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  • 

    

    Jeffrey Allen, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  MinuteCE®

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  • 

    

    Jeffrey Allen, MD

    Peer

  • 

    

    Nicholas J. Silvestri, MD

    Peer

  1.00 program credits
• advertisement

• 

  RestartResume

  Mastering ARIA Management: Charting the Path in a Virtual Clinic

  CME/CE

  Mastering ARIA Management: Charting the Path in a Virtual Clinic

  • 

    

    James R. Bateman, MD, MPH

    Peer

  0.25 credits

• 

  RestartResume

  Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

  CME/CE

  Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

  • 

    

    John Russell, MD

    Peer

  • 

    

    Noel Dasgupta, MD, FACC

    Peer

  • 

    

    Sami Khella, MD

    Peer

  0.50 credits

• 

  RestartResume

  Duchenne Muscular Dystrophy: Differentiating Advances in Treatment 

  CME/CE

  Duchenne Muscular Dystrophy: Differentiating Advances in Treatment 

  • 

    

    Omer Abdul Hamid, MD

    Peer

  • 

    

    Nancy Kuntz, MD

    Peer

  • 

    

    Migvis Monduy, MD

    Peer

  0.25 credits

• Prev
• 1
• 2
• …
• 4
• 5
• 6
• 7
• Next